Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares OutstandingShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2025)

Historic Shares Repurchased for Neurocrine Biosciences (NBIX) over the last 2 years, with Q2 2025 value amounting to $17.7 million.

  • Neurocrine Biosciences' Shares Repurchased changed N/A to $17.7 million in Q2 2025 from the same period last year, while for Dec 2025 it was $167.7 million, marking a year-over-year decrease of 4410.0%. This contributed to the annual value of $167.7 million for FY2025, which is 4410.0% down from last year.
  • As of Q2 2025, Neurocrine Biosciences' Shares Repurchased stood at $17.7 million.
  • Neurocrine Biosciences' 5-year Shares Repurchased high stood at $300.0 million for Q4 2024, and its period low was $17.7 million during Q2 2025.